Lv0
0 积分 2026-06-19 加入
Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes
23小时前
已完结
Evaluation of exacerbation severity in patients with COPD exacerbations according to the GOLD 2023 report
23小时前
已完结
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis
3个月前
已完结
Glucagon-like peptide-1 receptor agonists for improving quality of life and mortality in adults with heart failure with preserved ejection fraction: A systematic review and meta-analysis of efficacy and safety
3个月前
已关闭
GLP-1RA versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: An updated meta-analysis of randomized controlled trials
3个月前
已完结
Semaglutide Beyond Diabetes and Obesity: Systematic Review and Meta-Analysis of Multisystem Therapeutic Benefits
3个月前
已完结
Tirzepatide Beyond Diabetes and Obesity: Systematic Review and Meta-Analysis of Multisystem Therapeutic Benefits
3个月前
已关闭
Abstract 4371746: Comparative Study of Cardiovascular Safety of GLP-1 Receptor Agonists Across Indications: A Meta-Analysis of Randomized Controlled Trials in Type 2 Diabetes and Obesity
3个月前
已关闭
CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment
3个月前
已完结
Approved weight loss drugs for obesity with a thorough emphasis on GLP-1 agonist medications: A systematic review
3个月前
已完结
皖公网安备34019202002308
